Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, United Kingdom
Avloclor 250 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. |
Tablets containing 250 mg chloroquine phosphate, which is equivalent to 155 mg chloroquine base.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Chloroquine |
Chloroquine binds to and alters the properties of DNA. Chloroquine also binds to ferriprotoporphyrin IX and this leads to lysis of the plasmodial membrane. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite. |
| List of Excipients |
|---|
|
Magnesium stearate (E572) |
HDPE bottle of 100’s and PVC/Aluminium Foil Blister Pack of 20’s
Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, United Kingdom
PL 16853/0143
18/06/2000 / 03/06/2005
| Drug | Countries | |
|---|---|---|
| AVLOCLOR | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
